Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1993 | 06-1993 | 03-1993 | 12-1992 | 09-1992 | |
| Operating Expenses | 3,890 | 3,130 | 2,460 | 0 | 2,780 |
| Operating Income | -3,890 | -3,130 | -2,460 | N/A | -2,780 |
| Pre-tax Income | -3,890 | -3,130 | -2,460 | 0 | -2,780 |
| Net Income Continuous | -3,890 | -3,130 | -2,460 | N/A | -2,780 |
| Net Income | $-3,890 | $-3,130 | $-2,460 | $N/A | $-2,780 |
| EBITDA(a) | $-3,890 | $-3,130 | $-2,460 | $N/A | $-2,780 |